Dow (DOW)
(Delayed Data from NYSE)
$21.79 USD
-1.50 (-6.44%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $21.88 +0.09 (0.41%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Dow Inc. has a PEG ratio of 71.70 compared to the Chemical - Diversified industry's PEG ratio of 2.26.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DOW 21.79 -1.50(-6.44%)
Will DOW be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DOW based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DOW
Charles Schwab and Dow have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Dow (DOW)
DOW: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dow Inc. (DOW) Reports Q2 Earnings: What Key Metrics Have to Say
DOW Lags Q2 Earnings and Sales Estimates on Lower Prices
Dow Inc. (DOW) Reports Q2 Loss, Misses Revenue Estimates
Other News for DOW
ClearBridge Mid Cap Growth Portfolios Q2 2025 Commentary
Franklin Gold And Precious Metals Fund Q2 2025 Commentary
Franklin DynaTech SMA Q2 2025 Commentary
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
Franklin Small Cap Growth Fund Q2 2025 Commentary